Elisabetta Baglioni1, Letizia Trovato2, Marco Marcarelli3, Ambra Frenello1, Maria Alessandra Bocchiotti1. 1. Department of Plastic and Reconstructive Surgery, University of Turin, San Giovanni Battista Hospital, Turin, Italy. 2. Department of Medical Sciences, University of Turin, Turin, Italy letizia.trovato@unito.it. 3. Unit of Orthopedics and Traumatoly, Santa Croce Hospital, Moncalieri, Italy.
Abstract
BACKGROUND/AIM: The closure of postoperative wounds is essential in order to prevent surgical site infections or wound dehiscence, mainly in oncological patients. We aimed to demonstrate the efficacy of autologous micrografts in the management of wound dehiscence in an oncology patient undergoing decompressive spinal laminectomy. CASE REPORT: A 57-year-old man with IgG multiple myeloma and medullary plasmocytoma C7-T3, was to undergo decompressive spinal laminectomy and vertebral fixation leading to a wound dehiscence with exposed instrumentation. Autologous micrografts were obtained by Rigenera protocol and directly applied to the dehisced wound. After 60 days of negative pressure wound therapy, we observed reduction of the diameter and depth of wound dehiscence, with a coverage of instrumentation, without complete re-epithelialization, that instead was reached by application of autologous micrografts after 70 days. CONCLUSION: The Rigenera protocol may be the solution for complex wounds in oncological and immune-compromised patients where other treatments are contraindicated. Copyright
BACKGROUND/AIM: The closure of postoperative wounds is essential in order to prevent surgical site infections or wound dehiscence, mainly in oncological patients. We aimed to demonstrate the efficacy of autologous micrografts in the management of wound dehiscence in an oncology patient undergoing decompressive spinal laminectomy. CASE REPORT: A 57-year-old man with IgG multiple myeloma and medullary plasmocytoma C7-T3, was to undergo decompressive spinal laminectomy and vertebral fixation leading to a wound dehiscence with exposed instrumentation. Autologous micrografts were obtained by Rigenera protocol and directly applied to the dehisced wound. After 60 days of negative pressure wound therapy, we observed reduction of the diameter and depth of wound dehiscence, with a coverage of instrumentation, without complete re-epithelialization, that instead was reached by application of autologous micrografts after 70 days. CONCLUSION: The Rigenera protocol may be the solution for complex wounds in oncological and immune-compromised patients where other treatments are contraindicated. Copyright
Authors: Francesco De Francesco; Antonio Graziano; Letizia Trovato; Gabriele Ceccarelli; Maurizio Romano; Marco Marcarelli; Gabriella Maria Cusella De Angelis; Umberto Cillo; Michele Riccio; Giuseppe Andrea Ferraro Journal: Stem Cell Rev Rep Date: 2017-02 Impact factor: 5.739
Authors: Marco Viganò; Irene Tessaro; Letizia Trovato; Alessandra Colombini; Marco Scala; Alberto Magi; Andrea Toto; Giuseppe Peretti; Laura de Girolamo Journal: J Orthop Surg Res Date: 2018-11-06 Impact factor: 2.359
Authors: Marco Marcarelli; Marcello Zappia; Lorenzo Rissolio; Chiara Baroni; Carlo Astarita; Letizia Trovato; Antonio Graziano Journal: J Clin Med Date: 2021-01-17 Impact factor: 4.241
Authors: Ruggero Rodriguez Y Baena; Riccardo D'Aquino; Antonio Graziano; Letizia Trovato; Antonio C Aloise; Gabriele Ceccarelli; Gabriella Cusella; André A Pelegrine; Saturnino M Lupi Journal: Front Cell Dev Biol Date: 2017-09-27
Authors: Marco Mario Tresoldi; Antonio Graziano; Alberto Malovini; Angela Faga; Giovanni Nicoletti Journal: Stem Cells Int Date: 2019-09-08 Impact factor: 5.443
Authors: Michele Riccio; Andrea Marchesini; Nicola Zingaretti; Sara Carella; Letizia Senesi; Maria Giuseppina Onesti; Pier Camillo Parodi; Diego Ribuffo; Luca Vaienti; Francesco De Francesco Journal: Stem Cells Int Date: 2019-12-01 Impact factor: 5.443